A 2025 survey by KFF reported that 27 percent of people taking GLP-1 medications who had health insurance said that they still had to pay the full cost of the drugs out of pocket, however
If you have any concerns about your medication, please reach out to our office so we can discuss your treatment plan and ensure you have uninterrupted access to your medication
These effects account for the appetite reduction and blood sugar improvements that tirzepatide users report within the first few weeks
However, an important distinction often gets overlooked: GLP-1 medications are not approved for Type 1 diabetes and in this population, they may increase the risk of a dangerous complication called euglycemic diabetic ketoacidosis (DKA)
This means any caloric deficit must come from conscious dietary decisions rather than reduced appetite
B vitamins and the brain: mechanisms, dose, and efficacya review